GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SIZE TO CROSS USD 24 BILLION BY 2025, GROWING AT A CAGR OF 7% DURING THE FORECAST PERIOD

Infectious Disease Diagnostics Market Size, Share, Trends, Analysis Report by Product (Instruments/Analyzers and Software and Consumables), Disease (Hepatitis, AIDS, HAIs, Influenza, Tuberculosis, Malaria, HPV Infection, Sepsis, Dengue, and Other Diseases), End-users (Hospitals, Standard Reference Laboratories, Public Health Laboratories, Blood Banks, Acute Care Settings, and Others), Test (Traditional Diagnostics and Molecular Diagnostics), and Geography (APAC, Europe, North America, Latin America, and Middle East & Africa), Industry Analysis Report, Regional Outlook, Growth Trends, Competitive Landscape, Share & Forecast, 2020–2025

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

282 Pages

icon-table

151 Tables

icon-chart

47 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

24 Companies

icon-market

5 Market Segment

GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET REPORT SCOPE

Report Attribute Details
Market Size (REVENUE) USD 24 Billion (2025)
CAGR 7% (2020-2025)
Base Year 2019
Forecast Year 2020-2025
Market Segments Product (Instruments/Analyzers and Software and Consumables), Disease (Hepatitis, AIDS, HAIs, Influenza, Tuberculosis, Malaria, HPV Infection, Sepsis, Dengue, and Other Diseases), End-users (Hospitals, Standard Reference Laboratories, Public Health Laboratories, Blood Banks, Acute Care Settings, and Others), Test (Traditional Diagnostics and Molecular Diagnostics)
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered US, Canada, UK, Germany, France, Italy, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, and Turkey

INDUSTRY INSIGHTS

The global infectious disease diagnostics market size to cross USD 24 billion by 2025, growing at a CAGR of over 7% during the forecast period. The global infectious disease diagnostics market, which is one of the major segments in the global in-vitro diagnostics market, is likely to grow at a steady rate during the forecast period. The growth can be attributed to the growing prevalence/incidence of several infectious diseases. Malaria continues to be a major cause of death in the Middle East and Africa. The market is witnessing growth due to the increase in the usage of diagnostics testing for several purposes, including routine health checkups, infectious diseases, seasonal flu. Improvements in technology such as the introduction of automated analyzers, advanced devices with high throughput with reduced waiting time and point-of-care testing & diagnostics, and the ability to perform a large volume of tests in a shorter duration of time are fueling the global infectious disease diagnostics market growth.

SNIPPETS

  • The molecular segment is expected to grow at the highest CAGR of over 10% during the period 2019­–2025 due to the increased revenue contribution of polymerase chain reaction (PCR) technology.
  • The hospital-acquired infections (HAIs) segment is likely to reach over $9 billion by 2025. The usage of diagnostic techniques to diagnose several HAIs is considered as an important step to initiate several preventive measures. 
  • The consumable segment is likely to observe an incremental growth of over $7 billion by 2025 on account of the increasing sale of high-end instruments by hospitals, commercial labs, and other facilities. 
  • The standard reference laboratories segment is projected to over $8 billion by 2025, owing to the rise of private laboratories, especially in developing countries. 
  • The infectious disease diagnostics market in India is likely to grow at a CAGR of over 8% during the period 2019­­–2025 on account of the rapidly growing patient pool with infectious diseases and increased market access.

 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION

This research report includes a detailed segmentation by

  • Products
  • Disease
  • End-user
  • Tests
  • Geography

INSIGHTS BY TEST

In 2019, the traditional diagnostics segment accounted for 66% of the infectious disease diagnostics market share. The segment is growing at a moderate rate than molecular diagnostics. Conventional diagnostics include immunodiagnostics, blood culture tests, and clinical, microbiological methods to diagnose several diseases. However, the infectious disease molecular diagnostics market is rapidly capturing the revenue share of the traditional segment. Molecular diagnostic tests are based on DNA amplification techniques. They have comparatively higher sensitivity and specificity than immunoassays. Most tests are based on real-time PCR. However, these tests are comparatively complicated and expensive.

INSIGHTS BY DISEASE 

Tuberculosis (TB) segment is expected to be one of the major revenue contributors by 2025. By the end of 2018, around 10 million people were infected with TB, including 5.7 million men, 3.2 million women, and 1.1 million children. Therefore, the increasing burden of TB disease across the world, especially in India, China, South Africa, and Bangladesh constituting a significant percentage of TB cases, is likely to influence the segment growth.

The hepatitis segment is likely to grow at a CAGR of over 4% during the period 2019–2025. The staggering rise in liver damage cases due to viral infections, drug, and chemical abuses, and an increase in alcohol intake, is contributing to the growth of the segment. The presence of a high pool of infected patients who are undiagnosed and need urgent diagnosis is another driver influencing the segment growth. 

Improvements and enhancements in infectious disease testing methods for HIV testing and sexually transmitted disease is a major driver for the segment growth. Conventional methods for HIV testing, based on the detection of HIV-specific antibodies, have been improved over time, gaining in sensitivity and specificity. Kits that allow simultaneous determination of both HIV-specific antibodies and the p24 antigen have been recently introduced, thereby increasing the demand. There is a widespread concern of adverse effects of hospital-acquired infections (HAIs), which are increasing the market share of the Healthcare-associated Infections Diagnostics Market.  Healthcare providers and vendors are actively engaged in providing an expedited diagnosis of HAIs for quick clinical decision-making to support treatment regimens.

INSIGHTS BY END-USER  

The hospital end-user segment dominated the infectious disease diagnostics market shares. It accounted for the highest market share of over 34% in 2019 due to the high volume of infectious disease diagnosis and treatment performed in these settings. The large number of private hospitals, which have their central laboratories performing a high volume of tests, is a major factor influencing the market growth. Standard reference laboratories accounted for a share of 33% share. The number of standard reference laboratories (both private and public run labs) is increasing in large cities and urban areas of developing countries and developed countries due to an increase in epidemic conditions and the rise in prevalence of several infectious diseases such as malaria, dengue, and HIV. The demand for diagnosis is higher and plays a vital role in preventing the spread of acute diseases and take immediate preventive measures as well as help in making critical clinical decisions regarding treatment regimens. Public health laboratories accounted for a share of 12% in the end-user segment.

INSIGHTS BY PRODUCT

In 2019, the consumables segment accounted for 74% of the global infectious disease diagnostics market shares. The increasing share of consumables is due to the usage of a wide array of several standard reagents and test kits to perform various tests catering to the need of end-users. The usage of consumables is reoccurring in nature, and the consumables segment generates continuous revenue for vendors.

The instruments/ analyzers segment includes the capital equipment such as analyzers,  rapid diagnostics kit, assay instruments used for performing the routine as well as specialized tests. However, with rapid technological advancements, vendors are offering highly automated and semi-automated analyzers, which are replacing conventional testing methods. As the lifespan of analyzers is higher, they do not require repetitive purchases. The sale of the latest instruments /analyzers is higher in developed countries than in developing and under-developing countries due to the economic factors impacting the purchase of the advanced, costly equipment for the analysis.

INSIGHTS BY GEOGRAPHY

APAC is expected to grow at the highest CAGR of over 8% during the period 2019–2025. The region is witnessing the highest growth rate due to the high prevalence of infectious diseases in countries such as China, India, Japan, Australia, and South Korea. It is home to more than half of the world’s population, and the bulk of this population is still hugely underserved. The region is made up of diverse countries with varying needs. There are certain countries whose healthcare segment is developed, and a few countries’ healthcare infrastructures are still in infancy. However, the diagnostics market will have a high growth rate in this region due to the increase in infectious disease, combined with the aging population, which has put immense pressure on the healthcare resources in the region.

INSIGHTS BY VENDORS

The global infectious disease diagnostics industry is highly dynamic, with the presence of several global and local players offering a diverse range of instruments/analyzers and reagents. Abbott, BD, bioMérieux, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Luminex, Quidel, and Thermo Fisher Scientific are the leading players and accounted for significant shares in the market. Global players are focusing on developing innovative products and expanding their product portfolio to remain competitive in the market. They are investing extensively in R&D and product development activities to expand their product portfolio.

The global infectious disease testing market report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

 By Products 

  • Instruments/ Analyzers and Software
  • Consumables

By Disease   

  • Hepatitis
  • AIDS
  • HAIs
  • Influenza
  • Tuberculosis
  • Malaria
  • HPV Infection
  • Sepsis
  • Dengue
  • Other Diseases

By End-user  

  • Hospitals
  • Standard Reference Laboratories
  • Public Health Laboratories
  • Blood Banks
  • Acute Care Settings
  • Others

By Test

  • Traditional Diagnostics
  • Molecular Diagnostics

 By Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • South Korea
    • Australia
    • India
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Turkey
    • Iran

Frequently Asked Questions

What is the infectious disease diagnostics market size and growth rate during the forecast period?

Infectious disease diagnostics market size to cross $24 billion by 2025, growing at a CAGR of over 7% during the forecast period

What are the factors impacting the growth of the global infectious disease diagnostics market shares?

The market is witnessing growth due to the increase in the usage of diagnostic tests for several purposes, including routine health checkups, infectious diseases, seasonal flu.

Which product type/end-users/region is generating the largest revenue in the global market?

In 2019, the traditional diagnostics segment accounted for 66% of the infectious disease diagnostics market share.

Who are the leading vendors in the infectious disease diagnostics market, and what are their market shares?

Abbott, BD, bioMérieux, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Luminex, Quidel, and Thermo Fisher Scientific are the leading players and accounted for significant shares in the market.

How is the growth of the hospital segment influencing the growth of the infectious disease diagnostics market?

The hospital end-user segment accounted for the highest market share of over 34% in 2019 due to the high volume of infectious disease diagnosis and treatment performed in these settings

Download Free Sample

The infectious disease diagnostics market by revenue is expected to grow at a CAGR of over 7% during the period 2019–2025.

The following factors are likely to contribute to the growth of the infectious disease diagnostics market during the forecast period:

  • High Growth Potential in LMICs
  • Increasing Demand for Molecular Diagnostics
  • Strategic Merges and Acquisitions
  • Increased Prevalence of infectious Diseased Globally

Base Year:                  2019

Forecast Year:           2020–2025

The study considers the present scenario of the infectious disease diagnostics market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Prominent Vendors

  • Abbott
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • BD
  • bioMérieux
  • Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Quidel
  • Luminex
  • Danaher
  • Bio-Rad Laboratories

Other Prominent Vendors 

  • Meridian Bioscience
    • Business Overview
    • Product Offerings
  • DiaSorin Molecular
  • Accelerate Diagnostics
  • Trinity Biotech
  • OpGen
  • QIAGEN
  • Siemens Healthineers
  • caviid
  • EIKEN CHEMICAL
  • Epitope Diagnostics Inc.
  • EUROIMMUN
  • Genetic Signatures
  • Hologic
  • Oxford Immunotec
  • Seegene

Segmentation by Products 

  • Instruments/ Analyzers & Software
  • Consumables

Segmentation by Disease   

  • Hepatitis
  • AIDS
  • HAIs
  • Influenza
  • Tuberculosis
  • Malaria
  • HPV Infection
  • Sepsis
  • Dengue
  • Other Diseases

Segmentation by End-user  

  • Hospitals
  • Standard Reference Laboratories
  • Public Health Laboratories
  • Blood Banks
  • Acute Care Settings
  • Others

Segmentation by Test

  • Traditional Diagnostics
  • Molecular Diagnostics

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • South Korea
    • Australia
    • India
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Turkey
    • Iran

1              Research Methodology

2              Research Objectives

3              Research Process

 

4              Scope & Coverage

4.1          Market Definition

4.1.1      Inclusion

4.1.2      Exclusions

4.2          Base Year

4.3          Scope Of The Study

4.4          Market Segments

4.4.1      Market Segmentation by Product

4.4.2      Market Segmentation by Test

4.4.3      Market Segmentation by Disease

4.4.4      Market Segmentation by End-User

4.4.5      Market Segmentation by Geography

 

5              Report Assumptions & Caveats

5.1          Key Caveats

5.2          Currency Conversion

5.3          Market Derivation

 

6              Market at a Glance

7              Introduction

7.1          Overview

 

8              Market Opportunities & Trends

8.1          High Growth Potential In Low And Middle Income Countries (LMICS)

8.2          Increasing Demand For Molecular Diagnostics

8.3          Strategic Merges and Acquisitions

 

9              Market Growth Enablers

9.1          Increase In The Worldwide Prevalence Of Infectious Diseases

9.2          Shift From Centralized Laboratories To Point Of Care Testing

9.3          Technological Advancements And Launch Of More Reliable Products

 

10           Market Restraints

10.1        Availability of Advanced Control Mechanism For Infectious Disease

10.2        Inadequate Reimbursement

10.3        Poor Healthcare Infrastructure And Less Affordability In LMICS

 

11           Market Landscape

11.1        Market Overview

11.2        Market Size & Forecast

11.3        Five Forces Analysis

11.3.1    Threat of New Entrants

11.3.2    Bargaining Power of Suppliers

11.3.3    Bargaining Power of Buyers

11.3.4    Threat of Substitutes

11.3.5    Competitive Rivalry

 

12           Infectious Disease Diagnostics Market by Test

12.1        Market Snapshot & Growth Engine

12.2        Overview

12.3        Traditional Diagnostics

12.3.1    Overview

12.3.2    Size & Forecast

12.4        Molecular Diagnostics

12.4.1    Overview

12.4.2    Size & Forecast

 

13           Infectious Disease Diagnostics Market by Disease

13.1        Market Snapshot & Growth Engine

13.2        Overview

13.3        Hepatitis

13.3.1    Overview

13.3.2    Size & Forecast

13.4        HIV

13.4.1    Overview

13.4.2    Size & Forecast

13.5        Hospital Acquired Infections (HAIs)

13.5.1    Overview

13.5.2    Size & Forecast

13.6        Influenza

13.6.1    Overview

13.6.2    Size & Forecast

13.7        Tuberculosis

13.7.1    Overview

13.7.2    Size & Forecast

13.8        Malaria

13.8.1    Overview

13.8.2    Size & Forecast

13.9        Human Papilloma Virus

13.9.1    Overview

13.9.2    Size & Forecast

13.10     SEPSIS

13.10.1  Overview

13.10.2  Size & Forecast

13.11     Dengue

13.11.1  Overview

13.11.2  Size & Forecast

13.12     Other Infectious Diseases

13.12.1  Overview

13.12.2  Size & Forecast

 

14           Infectious Disease Diagnostics Market by Product

14.1        Market Snapshot & Growth Engine

14.2        Overview

14.3        Consumables

14.3.1    Overview

14.3.2    Size & Forecast

14.4        Instruments/Analyzers & Software

14.4.1    Overview

14.4.2    Size & Forecast

 

15           Infectious Disease Diagnostics Market by End-User

15.1        Market Snapshot & Growth Engine

15.2        Overview

15.3        Hospitals

15.3.1    Overview

15.3.2    Size & Forecast

15.4        Standard Reference Laboratories

15.4.1    Overview

15.4.2    Size & Forecast

15.5        Public Health Laboratories

15.5.1    Overview

15.5.2    Size & Forecast

15.6        Blood Banks

15.6.1    Overview

15.6.2    Size & Forecast

15.7        Acute Care Settings

15.7.1    Overview

15.7.2    Size & Forecast

15.8        Other End-User

15.8.1    Overview

15.8.2    Size & Forecast

 

16           Infectious Disease Diagnostics Market by Geography

16.1        Market Snapshot & Growth Engine

16.2        Geographic Overview

 

17           APAC

17.1        Market Overview

17.2        Size & Forecast

17.3        Key Countries

17.3.1    China: Infectious Disease Diagnostics Market Size & Forecast

17.3.2    Japan: Size & Forecast

17.3.3    India: Size & Forecast

17.3.4    South Korea: Size & Forecast

17.3.5    Australia: Size & Forecast

 

18           Europe

18.1        Market Overview

18.2        Size & Forecast

18.3        Key Countries

18.3.1    Germany: Infectious Disease Diagnostics Market Size & Forecast

18.3.2    France: Size & Forecast

18.3.3    UK: Size & Forecast

18.3.4    Italy: Size & Forecast

18.3.5    Spain: Size & Forecast

 

19           North America

19.1        Market Overview

19.2        Size & Forecast

19.3        Key Countries

19.3.1    US: Infectious Disease Diagnostics Market Size & Forecast

19.3.2    Canada: Size & Forecast

 

20           Latin America

20.1        Market Overview

20.2        Size & Forecast

20.3        Key Countries

20.3.1    Brazil: Infectious Disease Diagnostics Market Size & Forecast

20.3.2    Mexico: Size & Forecast

20.3.3    Argentina: t Size & Forecast

 

21           Middle East and Africa

21.1        Market Overview

21.2        Size & Forecast

21.3        Key Countries

21.3.1    South Africa: Infectious Disease Diagnostics Market Size & Forecast

21.3.2    Turkey: Size & Forecast

21.3.3    Saudi Arabia: Size & Forecast

21.3.4    Iran: Size & Forecast

 

22           Competitive Landscape

22.1        Competition Overview

22.2        Market Share Analysis

22.2.1    Abbott

22.2.2    BD

22.2.3    bioMérieux

22.2.4    DANAHER

22.2.5    Bio-Rad Laboratories

22.2.6    F.Hoffmann-LaRoche

22.2.7    Luminex

22.2.8    Quidel

22.2.9    Thermo Fischer Scientific

 

23           Key Company Profiles

23.1        Abbott in Infectious Disease Diagnostics Market

23.1.1    Business Overview

23.1.2    Product Offerings

23.1.3    Key Strategies

23.1.4    Key Strengths

23.1.5    Key Opportunities

23.2        BD in Infectious Disease Diagnostics Market

23.2.1    Business Overview

23.2.2    Product Offerings

23.2.3    Key Strategies

23.2.4    Key Strengths

23.2.5    Key Opportunities

23.3        bioMérieux in Infectious Disease Diagnostics Market

23.3.1    Business Overview

23.3.2    Product Offerings

23.3.3    Key Strategies

23.3.4    Key Strengths

23.3.5    Key Opportunities

23.4        F.Hoffmann-La Roche in Infectious Disease Diagnostics Market

23.4.1    Business Overview

23.4.2    Product Offerings

23.4.3    Key Strategies

23.4.4    Key Strengths

23.4.5    Key Opportunities

23.5        Thermo Fisher Scientific in Infectious Disease Diagnostics Market

23.5.1    Business Overview

23.5.2    Product Offerings

23.5.3    Key Strategies

23.5.4    Key Strengths

23.5.5    Key Opportunities

23.6        Quidel in Infectious Disease Diagnostics Market

23.6.1    Business Overview

23.6.2    Product Offerings

23.6.3    Key Strategies

23.6.4    Key Strengths

23.6.5    Key Opportunities

23.7        Luminex in Infectious Disease Diagnostics Market

23.7.1    Business Overview

23.7.2    Product Offerings

23.7.3    Key Strategies

23.7.4    Key Strengths

23.7.5    Key Opportunities

23.8        Danaher in Infectious Disease Diagnostics Market

23.8.1    Business Overview

23.8.2    Product Offerings

23.8.3    Key Strategies

23.8.4    Key Strengths

23.8.5    Key Opportunities

23.9        Bio-Rad Laboratories in Infectious Disease Diagnostics Market

23.9.1    Business Overview

23.9.2    Product Offerings

23.9.3    Key Strategies

23.9.4    Key Strengths

23.9.5    Key Opportunities

 

24           Other Prominent Vendors

24.1        Meridian Bioscience

24.1.1    Business Overview

24.1.2    Product Offerings

24.2        DiaSorin Molecular

24.2.1    Business Overview

24.2.2    Product Offerings

24.3        Accelerate Diagnostics

24.3.1    Business Overview

24.3.2    Product Offerings

24.4        Trinity Biotech

24.4.1    Business Overview

24.4.2    Product Offerings

24.5        OpGen

24.5.1    Business Overview

24.5.2    Product Offerings

24.6        Qiagen

24.6.1    Business Overview

24.6.2    Product Offerings

24.7        Siemens Healthineers

24.7.1    Business Overview

24.7.2    Product Offerings

24.8        cavidi

24.8.1    Business Overview

24.8.2    Product Offerings

24.9        EIKEN Chemical

24.9.1    Business Overview

24.9.2    Product Offerings

24.10     Epitope Diagnostics

24.10.1  Business Overview

24.10.2  Product Offerings

24.11     Euroimmun

24.11.1  Business Overview

24.11.2  Product Offerings

24.12     Genetic Signatures

24.12.1  Business Overview

24.12.2  Product Offerings

24.13     Hologic

24.13.1  Business Overview

24.13.2  Product Offerings

24.14     Oxford Immunotec

24.14.1  Business Overview

24.14.2  Product Offerings

24.15     Seegene

24.15.1  Business Overview

24.15.2  Product Offerings

 

25           Report Summary

25.1        Key Takeaways

25.2        Strategic Recommendations

 

26           Quantitative Summary

26.1        Market By Geography

26.2        Market By End-User

26.3        Market By Test

26.4        Market By Product

26.5        Market By Disease

 

27           Appendix

27.1        Abbreviations

               

 

List Of Exhibits 

Exhibit 1               Segmentation of Global Infectious Disease Diagnostics Market

Exhibit 2               Market Size Calculation Approach 2019

Exhibit 3               Impact of High Growth Potential in LMICs

Exhibit 4               Leading Causes of Death in Low-Income Countries -2016 (deaths per 100,000 Population)

Exhibit 5               Impact of Increasing Demand for Molecular Diagnostics

Exhibit 6               Number of Death Globally due to Drug-Resistant Infections

Exhibit 7               Impact of Strategic Merges and Acquisitions

Exhibit 8               Impact of Increase in the Worldwide Prevalence of Infectious Diseases

Exhibit 9               Regional Prevalence of Several Infectious Diseases

Exhibit 10             Global Number of Human Infectious Disease Outbreaks and Pathogen Taxonomy (Past four decades comparison)

Exhibit 11             Impact of Shift from Centralized Laboratories to Point of Care Testing

Exhibit 12             Impact of Technological Advancements and Launch of More Reliable Products

Exhibit 13             Impact of Availability of Advanced Control Mechanism for Infectious Disease

Exhibit 14             The Control Mechanism for the Infectious Diseases

Exhibit 15             Steps & Strategies by the WHO for Infectious Diseases

Exhibit 16             Impact of Inadequate Reimbursement

Exhibit 17             Effects of Limitations to Reimbursement System

Exhibit 18             Impact of Poor Healthcare Infrastructure and Less Affordability in LMICs

Exhibit 19             Availability of Healthcare Service

Exhibit 20             Global Infectious Disease Diagnostics Market by Product

Exhibit 21             Global Infectious Disease Diagnostics Market by Test

Exhibit 22             Global Infectious Disease Diagnostics Market by Disease

Exhibit 23             Global Infectious Disease Diagnostics Market by End-user

Exhibit 24             Global Infectious Disease Diagnostics Market by Geography

Exhibit 25             Global Infectious Disease Diagnostics Market 2019–2025 ($ billion)

Exhibit 26             Five Forces Analysis 2019

Exhibit 27             Incremental Growth by Test 2019 & 2025

Exhibit 28             Global Infectious Disease Diagnostics Market by Test

Exhibit 29             Global Market by Test: Incremental Growth ($ billion)

Exhibit 30             Global Market by Test: Absolute Growth (%)

Exhibit 31             Global Market by Traditional Diagnostics: Incremental Growth Versus Absolute Growth

Exhibit 32             Global Market – Traditional Diagnostics 2019–2025 ($ billion)

Exhibit 33             Global Market by Molecular Diagnostics: Incremental Growth Versus Absolute Growth

Exhibit 34             Global Market- Molecular Diagnostics 2019–2025 ($ billion)

Exhibit 35             Incremental Growth by Disease 2019 & 2025

Exhibit 36             Global Infectious Disease Diagnostics Market by Disease

Exhibit 37             Global Market by Hepatitis Disease: Incremental Growth Versus Absolute Growth

Exhibit 38             Global Market – Hepatitis 2019–2025 ($ billion)

Exhibit 39             Prevalence of HIV by Region

Exhibit 40             Global Market by HIV Disease: Incremental Growth Versus Absolute Growth

Exhibit 41             Global Market – HIV 2019–2025 ($ billion)

Exhibit 42             Global Hospital Acquired Market by Infection Type 2018 (%)

Exhibit 43             Global Market by HAI: Incremental Growth Versus Absolute Growth

Exhibit 44             Global Market- HAI 2019–2025 ($ billion)

Exhibit 45             Global Market by Influenza: Incremental Growth Versus Absolute Growth

Exhibit 46             Global Market – Influenza 2019–2025 ($ billion)

Exhibit 47             Regional Prevalence of TB

Exhibit 48             Global Market by TB: Incremental Growth Versus Absolute Growth

Exhibit 49             Global Market– Tuberculosis2019–2025 ($ billion)

Exhibit 50             Global Market by Malaria: Incremental Growth Versus Absolute Growth

Exhibit 51             Global Market- Malaria 2019–2025 ($ billion)

Exhibit 52             Global Market by HPV: Incremental Growth Versus Absolute Growth

Exhibit 53             Global Market – HPV 2019–2025 ($ billion)

Exhibit 54             Global Market by Sepsis: Incremental Growth Versus Absolute Growth

Exhibit 55             Global Market – Sepsis 2019–2025 ($ billion)

Exhibit 56             Global Market by Dengue: Incremental Growth Versus Absolute Growth

Exhibit 57             Global Market – Dengue 2019–2025 ($ billion)

Exhibit 58             Global Market by Other Diseases: Incremental Growth Versus Absolute Growth

Exhibit 59             Global Market- Other Diseases 2019–2025 ($ billion)

Exhibit 60             Incremental Growth by Product 2019 & 2025

Exhibit 61             Global Infectious Disease Diagnostics Market by Product

Exhibit 62             Global Market by Product: Incremental Growth ($ billion)

Exhibit 63             Global Market by Product: Absolute Growth (%)

Exhibit 64             Global Market by Consumables: Incremental Growth Versus Absolute Growth

Exhibit 65             Global Market- Consumables 2019–2025 ($ billion)

Exhibit 66             Global Market by Instruments/Analyzers & Software: Incremental Growth Versus Absolute Growth

Exhibit 67             Global Market – Instrument /Analyzers & Software 2019–2025 ($ billion)

Exhibit 68             Incremental Growth by End-User 2019 & 2025

Exhibit 69             Global Infectious Disease Diagnostics Market by End-User

Exhibit 70             Global Market by End-user: Incremental Growth ($ billion)

Exhibit 71             Global Market by Hospitals: Incremental Growth Versus Absolute Growth

Exhibit 72             Global Infectious Diagnostics Market- Hospitals 2019–2025 ($ billion)

Exhibit 73             Global Market by Standard Reference Laboratories: Incremental Growth Versus Absolute Growth

Exhibit 74             Global Market- Standard Reference Laboratories 2019–2025 ($ billion)

Exhibit 75             Global Market by Public Health Laboratories: Incremental Growth Versus Absolute Growth

Exhibit 76             Global Market – Public Health Laboratories 2019–2025 ($ billion)

Exhibit 77             Global Market by Blood Banks: Incremental Growth Versus Absolute Growth

Exhibit 78             Percentage Share of Blood Donations in Various Countries by Income

Exhibit 79             Global Market- Blood Banks 2019–2025 ($ billion)

Exhibit 80             Global Market by Acute Care Settings: Incremental Growth Versus Absolute Growth

Exhibit 81             Global Market-Acute Care Settings 2019–2025 ($ billion)

Exhibit 82             Global Market by Other End-User: Incremental Growth Versus Absolute Growth

Exhibit 83             Global Market- Other End-User 2019–2025 ($ billion)

Exhibit 84             Incremental Growth by Geography 2019 & 2025

Exhibit 85             Global Infectious Disease Diagnostics Market by Geography

Exhibit 86             Global Market by Geography: Incremental Growth ($ billion)

Exhibit 87             Global Market by Geography: Absolute Growth (%)

Exhibit 88             Infectious Disease Diagnosis Market in APAC: Key Countries 2019 ($ billion)

Exhibit 89             Infectious Disease Diagnostics Market in APAC: Incremental Growth Versus Absolute Growth Comparison

Exhibit 90             Market in APAC 2019–2025 ($ billion)

Exhibit 91             Incremental Growth in APAC 2019 & 2025

Exhibit 92             Market in China 2019–2025 ($ billion)

Exhibit 93             Market in Japan 2019–2025 ($ billion)

Exhibit 94             Market in India 2019–2025 ($ billion)

Exhibit 95             Market in South Korea 2019–2025 ($ billion)

Exhibit 96             Market in Australia 2019–2025 ($ billion)

Exhibit 97             Infectious Disease Diagnosis Market in Europe: Key Countries 2019 ($ million)

Exhibit 98             Infectious Disease Diagnostics Market in Europe: Incremental Growth Versus Absolute Growth Comparison

Exhibit 99             European IVD Market Per capita – 2018 (Euros - million)

Exhibit 100          European IVD Market – 2018 (Euros - million)

Exhibit 101          Market in Europe 2019–2025 ($ billion)

Exhibit 102          Incremental Growth in Europe 2019 & 2025

Exhibit 103          Market in Germany 2019–2025 ($ billion)

Exhibit 104          Market in France 2019–2025 ($ billion)

Exhibit 105          Market in UK 2019–2025 ($ billion)

Exhibit 106          Market in Italy 2019–2025 ($ billion)

Exhibit 107          Market in Spain 2019–2025 ($ billion)

Exhibit 108          Infectious Disease Diagnosis Market in North America: Key Countries 2019 ($ billion)

Exhibit 109          Infectious Disease Diagnostics Market in North America: Incremental Growth Versus Absolute Growth Comparison

Exhibit 110          Market in North America 2019–2025 ($ billion)

Exhibit 111          Incremental Growth in North America 2019 & 2025

Exhibit 112          Market in US 2019–2025 ($ billion)

Exhibit 113          New Cases of Infectious Disease 2016 & 2017

Exhibit 114          Number of Labs by Type in US

Exhibit 115          Percentage of Lab Test Volumes

Exhibit 116          Market in Canada 2019–2025 ($ billion)

Exhibit 117          Infectious Disease Diagnosis Market in Latin America: Key Countries 2019 ($ billion)

Exhibit 118          Infectious Disease Diagnostics Market in Latin America: Incremental Growth Versus Absolute Growth Comparison

Exhibit 119          Market in Latin America 2019–2025 ($ billion)

Exhibit 120          Incremental Growth in Latin America 2019 & 2025

Exhibit 121          Market in Brazil 2019–2025 ($ billion)

Exhibit 122          Market in Mexico 2019–2025 ($ billion)

Exhibit 123          Market in Argentina 2019–2025 ($ billion)

Exhibit 124          Infectious Disease Diagnosis Market in Middle East and Africa: Key Countries 2019 ($ billion)

Exhibit 125          Infectious Disease Diagnostics Market in Middle East and Africa: Incremental Growth Versus Absolute Growth Comparison

Exhibit 126          Market in Middle East and Africa 2019–2025 ($ billion)

Exhibit 127          Incremental Growth in Middle East & Africa 2019 & 2025

Exhibit 128          Market in South Africa 2019–2025 ($ billion)

Exhibit 129          Market in Turkey 2019–2025 ($ billion)

Exhibit 130          Market in Saudi Arabia 2019–2025 ($ billion)

Exhibit 131          Market in Iran 2019–2025 ($ billion)

Exhibit 132          Global Infectious Disease Diagnostics Market: Vendors Market Share

Exhibit 133          Abbott: Sales Breakdown by Segments in 2018 & 2019 ($ million)

Exhibit 134          Abbott: Net Sales 2017−2019 ($ million)

Exhibit 135          Abbott: Net Sales breakdown by Diagnostics Product Segment 2018 & 2019 ($ million)

Exhibit 136          BD Revenue 2017−2019 ($ million)

Exhibit 137          BD: Research & Development Expenditure 2017−2019 ($million)

Exhibit 138          BD Revenue by Business Segment (billion)

Exhibit 139          F. Hoffmann-La Roche: Revenue by Segment 2018 & 2019 ($ billion)

Exhibit 140          F. Hoffmann-La Roche: Revenue by Geographies 2019 (%)

Exhibit 141          Thermo Fisher Scientific: Revenue 2017−2019 ($ million)

Exhibit 142          Thermo Fisher Scientific: Revenue by Geography 2019 (%)

Exhibit 143          Danaher: Revenue by Segment 2018 & 2019 ($ million)

Exhibit 144          Danaher: Net Sales 2017−2019 ($ million)

Exhibit 145          Danaher: Revenue by Geography 2019

Exhibit 146          Danaher: R&D Expenditure 2017−2019 ($ million)

Exhibit 147          Danaher: Diagnostics Segment Sales 2017−2019 ($ million)

Exhibit 148          Bio-Rad Laboratories: Net Sales by Geography 2019 ($ million)

Exhibit 149          Bio-Rad Laboratories Net Sales 2017−2019 ($ million)

Exhibit 150          Bio-Rad Laboratories: Net Sales by Segment 2018 & 2019 ($ million)

Exhibit 151          Bio-Rad Laboratories: R&D Expenditure 2017−2019 ($ million)

               

               

List Of Tables    

Table 1                  Key Caveats

Table 2                  Currency Conversion 2013−2019

Table 3                  Prominent Outbreaks, Epidemics and Pandemics

Table 4                  Main Causes of Death due to Infectious Diseases

Table 5                  Comparison of Absolute Growth in High Income and LMICs

Table 6                  Popular Mergers and Acquisitions in Infectious Disease Diagnostics Market

Table 7                  Recent Product Approval/Launch for Infectious Disease Diagnostics

Table 8                  Incremental & Absolute Growth Comparison – Disease (billion)

Table 9                  Various Diagnostics for HIV

Table 10               Influenza Virus Diagnosis Methods

Table 11               Diagnostic Tests for Malaria

Table 12               FDA Approved Laboratory Test for Human Papillomavirus

Table 13               Product Offerings For Other Infectious Diseases

Table 14               Commonly Performed Tests for the Donor Blood Samples

Table 15               Abbott: Major Product Offerings

Table 16               BD: Major Product Offerings

Table 17               bioMerieux: Major Product Offerings

Table 18               F.Hoffmann-LaRoche: Major Product Offerings

Table 19               Thermo Fisher Scientific: Major Product Offerings

Table 20               Quidel: Major Product Offerings

Table 21               Luminex: Major Product Offerings

Table 22               Danaher: Major Product Offerings

Table 23               Bio-Rad Laboratories: Major Product Offerings

Table 24               Meridian Bioscience: Major Product Offerings

Table 25               DiaSorin Molecular: Major Product Offerings

Table 26               Accelerate Diagnostics: Major Product Offerings

Table 27               Trinity Biotech: Major Product Offerings

Table 28               OpGen: Major Product Offerings

Table 29               Qiagen: Major Product Offerings

Table 30               Siemens Healthineers: Major Product Offerings

Table 31               cavidi: Major Product Offerings

Table 32               EIKEN CHEMICAL: Major Product Offerings

Table 33               Epitope Diagnostics: Major Product Offerings

Table 34               EUROIMMUN: Major Product Offerings

Table 35               Genetic Signatures: Major Product Offerings

Table 36               Hologic: Major Product Offerings

Table 37               Oxford Immunotec: Major Product Offerings

Table 38               Seegene: Major Product Offerings

Table 39               Global Infectious Disease Diagnostics Market by Geography 2019−2025 ($ billion)

Table 40               Global Market by Geography 2019−2025 (%)

Table 41               Global Infectious Disease Diagnostics Market by End-user 2019−2025 ($ billion)

Table 42               Global Market by End-User 2019−2025 (%)

Table 43               Global Infectious Disease Diagnostics Market by Test 2019−2025 ($ billion)

Table 44               Global Market by Test 2019−2025 (%)

Table 45               Global Infectious Disease Diagnostics Market by Product 2019−2025 ($ billion)

Table 46               Global Market by Product 2019−2025(%)

Table 47               Global Infectious Disease Diagnostics Market by Disease 2019−2025 ($ billion)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date